This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duggan, C., Schmidt, M., Lawler, M. et al. The prothrombin gene variant G20210A but not factor V Leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant 24, 693–694 (1999). https://doi.org/10.1038/sj.bmt.1701952
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701952
This article is cited by
-
Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells
Scientific Reports (2015)
-
Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?
Bone Marrow Transplantation (2005)
-
Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcome
Bone Marrow Transplantation (2002)
-
Factor V Leiden mutation as a predisposing factor for veno-occlusive disease following BMT
Bone Marrow Transplantation (2000)